This dual role—chaperoning oncogenic client proteins (e.g., HIF-1α, NF-κB) and acting extracellularly as a DAMP to modulate immune cell recruitment—positions HSP90 as a bridge between tumor-cell-intrinsic survival mechanisms and the host immune response. Here, HSP90AA1 is linked to neoplasm.